Singapore markets closed
Straits Times Index
3,265.95 +1.42 (+0.04%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
61,178.43 -1,200.40 (-1.92%) CMC Crypto 200
1,318.49 +18.39 (+1.41%)
LLY Mar 2025 780.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:23PM EDT. Market open.
| Previous close | 91.00 |
| Open | 91.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 780.00 |
| Expiry date | 2025-03-21 |
| Day's range | 91.00 - 91.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 27 |
- Thomson Reuters StreetEvents
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BenzingaWhat About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Tuesday, the FDA said it would convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee on Monday, June 10, 2024, to discuss Eli Lilly and Co’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually. The Phase 3 study submitted as part of this application, TRAILBLAZER-ALZ 2, is a double-blind, placebo-controlled study to evaluate the safety and efficacy of donanemab in pa
© 2024 Yahoo. All rights reserved.